Published: 2021-08-27

Viral clearance in COVID-19 patients admitted in designated COVID hospital in Western India

Harpreet Singh, Kanwaljit Kaur, S. K. Ghai, Pranaya Gurmeet, Raju Agarwal, Vipul Dutt, Sudheer K. Singh, Barun Bhai Patel


Background: COVID-19 pandemic is one of the greatest challenges faced worldwide and has not only posed health crisis but also had social, economic and political devastating effects. The speedy transmission risk enforced bygone practices of quarantine of healthy persons and isolation of all positive patients. The basis of all key policy making is the understanding of virus clearance from the body so that transmission can be ceased. The aim of the study was to understand the viral clearance and its’ co-relates for guiding infection control and transmission practices in COVID-19.

Methods: Cross sectional study in a tertiary care hospital. A cross-sectional study of total 398 patients admitted for COVID-19 between June 2020 and November 2020 at a tertiary care centre. Statistical analysis used: frequency, percentage, and chi square test Chi square test for linear trend and was used to find association.

Results: 88.19% were males and 11.81% were female patients, mean age of study participants was 34.84 years. 61.56% were symptomatic and among them 1.64% presented with severe symptoms. Mean duration to turn RT-PCR negative was 11.83 days. No significant difference in time taken to turn RT-PCR negative among asymptomatic and symptomatic cases is suggestive of no difference in viral load and its clearance in symptomatic vs asymptomatic cases.

Conclusions: The disease profile of COVID-19 in our setup was alike the national disease profile and the recovery rate being 98.76%. Presence of co-morbidities affects viral clearance in COVID-19.


COVID-19 cases, Tertiary care centre, Virus clearance

Full Text:



Government of India, Ministry of Health and Family. Welfare Guidelines on Clinical management of severe acute respiratory illness (SARI) in suspect/confirmed novel corona virus (nCoV) cases, 2019. Available at: pdf/Guidance%20document% 20-%202019-nCoV.pdf. Accessed on 18 July 2021.

WHO. Criteria for releasing COVID-19 patients from isolation, 2020. Available at: newsroom/commentaries/detail/criteriaforreleasingcovid-19-patients-fromisolation. Accessed on 18 July 2021.

3. Government of India, Ministry of Health and Family Welfare. Revised Discharge Policy for COVID-19, 2021. Available at: https://www.mohfw. Accessed on 18 July 2021.

Indian Council of Medical Research. Evidence based advisory on correlation of COVID-19 Diseases Severity with Ct values of the Real Time RT-PCR test, 2020. Available at: Accessed on 18 July 2021.

Lechien JR, Estomba CM, Place S, Laethem Y, Cabaraux P, Mat Q, et al. Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019. J Intern Med. 2020;288(3):335-44.

Voinsky I, Baristaite G, Gurwitz D. Effects of age and sex on recovery from COVID-19: Analysis of 5769 Israeli patients. J Infect. 2020;81(2):102-3.

Conti P, Younes A. Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection. J Biol Regul Homeost Agents. 2020;34(2):339-43.

Gudbjartsson DF, Helgason A, Jonsson H, Magnusson OT, Melsted P, Norddahl GL, et al. Spread of SARS-CoV-2 in the Icelandic Population. N Engl J Med. 2020;382(24):2302-15.

Wu J, Li W, Shi X, Chen Z, Jiang B, Liu J, et al. Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID-19). J Intern Med. 2020;288(1):128-38.